Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Bilirubin Blood Test Market Share

ID: MRFR//0249-CR | 148 Pages | Author: Kinjoll Dey| August 2019

The healthcare industry is experiencing substantial growth in the realm of device development, marked by significant technological advancements focusing on portability and energy efficiency. The emergence of portable or handheld diagnostic devices is revolutionizing patient care, empowering specialists to conduct diagnoses anywhere and at any time. These portable devices offer a myriad of features, providing technicians with unprecedented flexibility and efficiency.
One of the key advantages of portable diagnostics devices is their ability to eliminate the traditional constraints associated with time-consuming sample draws, laboratory scheduling, and processing costs. These devices are designed to be rechargeable, offering the convenience of mobility and ensuring that measurements can be taken and displayed digitally. The integration of digital technology in these devices is expected to enhance the accuracy of measurements, providing more reliable results for healthcare professionals.

Manufacturers in the healthcare sector are directing their efforts toward the development of products that predominantly employ non-invasive methods. This strategic focus aims to alleviate the stress and discomfort experienced by patients during diagnostic procedures. A noteworthy example is Koninklijke Philips N.V., a leading player in the healthcare device industry. The company has introduced its innovative bilichek system, a handheld, non-invasive bilirubin measurement device. Renowned for its ease of use and accurate digital measurements, this device exemplifies the industry's commitment to enhancing patient experience through cutting-edge technology.

The demand for portable and handheld diagnostic devices is on the rise, driven by the exceptional features and benefits they offer. These devices not only empower healthcare professionals with the flexibility to conduct on-the-spot diagnostics but also contribute to overall cost reduction by streamlining traditional diagnostic processes.

The portability of these devices plays a pivotal role in facilitating healthcare services in diverse settings, from traditional medical facilities to remote or underserved areas. The ability to perform diagnostics outside of a standard clinical environment enhances accessibility to healthcare, particularly in regions with limited infrastructure.

The digital screens integrated into these devices not only provide real-time measurement results but also contribute to the ease of interpretation and documentation. The transition from traditional analog methods to digital technology represents a significant leap forward in healthcare diagnostics, promising more accurate and efficient patient care.

As the healthcare industry continues to embrace the era of portable and handheld diagnostic devices, it is expected that manufacturers will focus on refining and expanding the capabilities of these technologies. The ongoing advancements in device miniaturization, energy efficiency, and data connectivity are poised to further transform the landscape of healthcare diagnostics.

The increasing demand for portable and handheld diagnostic devices underscores a paradigm shift in healthcare delivery. These devices are not merely instruments of diagnosis; they represent a commitment to patient-centric care, leveraging technology to enhance accessibility, accuracy, and overall efficiency in the healthcare ecosystem. As manufacturers continue to innovate in this space, the future holds the promise of even more advanced and accessible healthcare solutions for diverse populations worldwide.

Covered Aspects:

Report Attribute/Metric Details
Base Year For Estimation   2021
Historical Data 2020
Forecast Period   2030
Growth Rate 6.30%

Bilirubin Blood Test Market Analysis:


A yellowish-orange substance present in the human blood is called bilirubin. This natural coloring is secreted by our liver. It is discharged in bile and is formed from the breaking down of hemoglobin. From the blood, it reaches the liver and gets stored there. Bilirubin gets removed from the body through excretory passages. The condition of high bilirubin level is common in infants. It results in the yellowing of skin and eyes. A bilirubin blood test is conducted to check the level of yellow bilirubin in the blood. When the liver is functioning properly, it expels all the bilirubin from the body. In case the level of bilirubin is high, it gets drained from the liver and causes diseases such as jaundice, dark urine, and others. A high bilirubin blood test enables us to monitor the count of bilirubin in the blood, therefore, detects the problems related to gallbladders.


Bilirubin Blood Test Market size is calculated to index a 6.30% CAGR. It is estimated that its market value will shoot up to USD 2.32 Billion during the forecast (2022-2030).


Covid19 Analysis


Due to the spread of infectious coronavirus, people are facing several respiratory problems. Many patients have reported high blood test bilirubin levels, which is a serious concern. Although the death rate because of rising in bilirubin level is not high.


The government and medical agencies are investing in Research & Development programs. It will make rapid diagnosis easy. Low bilirubin blood test and high bilirubin blood test include a cumbersome process of sample collection, fluid handling, device packaging, etc. Therefore, a need arises to develop more effective ways of conducting the bilirubin blood test with the least spoilage.


Market Dynamics


Drivers


The diseases such as jaundice, dark urine, and problems related to the gallbladder, are increasing rapidly. It is leading to the rise in demand for bilirubin blood testing apparatus. New-born children or infants are more prone to such problems because their liver is not absorbing bilirubin properly immediately after their birth. This has boosted the market demand for portable and easy-to-use testing kits. Thus, the bilirubin blood test market size is expected to grow rapidly throughout the forecasted period.


Opportunities


Bilirubin blood test market growth can be attributed to the constant technological changes. The need for developing new apparatus and techniques of testing is increasing so that more accurate and trustworthy results can be drawn. The transferable and easy-to-use testing kits are being developed for this purpose. People are becoming aware and are adapting to a healthy lifestyle. The government of every nation is also investing its resources in healthcare camps where a large number of people are treated. This has amplified the bilirubin blood testing percentage.


Restraints


Some other sorts of testing techniques that are being used by people or agencies other than the pathological labs or research institutes are proposing a real threat to bilirubin blood testing market size. The test conducted by non-pathological personnel is not trustworthy and can show false results.


Value Chain Analysis


The key players in the field of the bilirubin blood test market are making technological advancements. They are launching such instruments which will require a minimum ounce of blood for testing the level of bilirubin in the blood of a patient. As the cases of jaundice are more in infants and newborns, the companies are developing techniques that will be less painful and will cause no harm to them.


Market Segmentation


Bilirubin blood test market can be divided into various segments. These are: based on test type, based on product type, based on application, and based on end-users.


Based on test type


Various kinds of tests conducted in bilirubin blood test market are as follows: Total Serum Bilirubin (TSB); Direct/Conjugated Bilirubin Test; Indirect/Unconjugated Bilirubin Test


Based on product type


Based on product type, the bilirubin blood test market is divided into two types, namely, consumables and instruments. Consumables are not reusable materials. Consumables alone accounted for a market stake of 47.37% in the year 2015, which was the highest among all other segments. The instruments can further be classified into analyzers and bilirubin meters.


Based on application


The market is divided into infants or newborn children and adults. The chances of jaundice in pediatrics are more than that of adults, therefore, infants form the largest percentage of the consumers of the bilirubin blood test market.


Based on end-users


Bilirubin blood testing is done at diagnostics centers, pathological labs, and hospitals. Research laboratories and other academic institutions also contribute a large share to the market. Pediatric clinics and child specialist hospitals are also end-user.


Regional Analysis


Bilirubin blood test market size is increasing with every passing day. It is leaving its impression in every corner of the world. The regions where they are operating include North America, Europe, Asia-pacific, and the rest of the world.


North America, which includes the area of the US and Canada, is overshadowing all the other regions. It accounted for a share of 39.10% in the year 2014, which was the largest in the global bilirubin blood test market. The market share of the US alone is anticipated to reach a CAGR of 4.93%.


The European region, which includes Germany, UK, France, Russia, and Italy, has bagged the position of second-largest market share in the bilirubin blood test market. It is presumed that Germany will touch the largest value, accounting for USD 158.6 million, by the end of the year 2027.


Asia-Pacific region, which includes China, Japan, India, Australia, and South Korea, provides a huge market for bilirubin blood testing. It owns to the fact that the government of these countries is investing a large share of their resources in developing a robust medical infrastructure. The market of these regions will grow with a CAGR of 6.45%. China alone had a market share of 34.10% in the year 2015.


The rest of the world, which includes regions of the Middle East and Africa, is showing a constant but slow growth because of the limited resources with the government and lack of awareness among the general public.


Competitive Landscape


The list of major key players involved in the global bilirubin blood test market analysis is as follows:



  • Koninklijke Philips N.V. (Noord-Holland)

  • Beckman Coulter, Inc. (US)

  • Thermo Fisher Scientific Inc. (US)

  • Randox Laboratories Ltd. (UK)

  • Hoffmann-La Roche AG (Switzerland)

  • Drägerwerk AG & Co. KGaA (Germany)

  • Ginevri (Italy)

  • Advanced Instruments (US)

  • Reichert, Inc. (US)

  • Instrumentation Laboratory (US).

  • AVI Healthcare Pvt. Ltd.


The above-listed companies work on the testing and origination of new equipment and techniques in the field of bilirubin blood testing. They come together in joint ventures, mergers, and, acquisitions, launching new devices. Their main objective is to deliver devices that are cost-effective, hassle-free in operations, and give concrete results.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.